Speaker: Robert C. Tasker, MBBS, MD, MA, FRCP, RCPCH
Robert C. Tasker, MBBS, MD, MA, FRCP, RCPCH: Welcome. My name is Robert Tasker and I'm your Editor-in-Chief of Pediatric Critical Care Medicine. August 2024, another great issue. This time, all about clinical innovations. My three Editor's Choices start with first, early echo to address fluid strategy in patients requiring mechanical ventilation and vasoactive agents. This is a study by Ip et al. It's retrospective single center, 2011 to 2020, 249 patients. Very interesting results. There is an accompanying editorial. The second study or second report is about rapid whole genome sequencing by Rodriguez et al. This is a follow-on study from some work that we published a while back. 2016 to 2018. This is now 2016 to 2023, 133 patients and there is an accompanying editorial. My third editor's choice article is about anticonvulsant prophylaxis for status epilepticus in traumatic brain injury. This is by Ahmed et al. This is a post hoc analysis of the ADAPT trial which was 2014 to 2017. The authors have looked at phenytoin versus levetiracetam, over 500 patients in the analysis. There's an accompanying editorial. In the two other sections to do with education we first have PCCM Connections and this is all about acute brain dysfunction in sepsis. It's based around Alcamo et al's paper on computational phenotype in identifying these patients. There is an accompanying editorial. Lastly in PCCM International, we have a randomized control trial about two different forms of noninvasive ventilation from India by Maya et al. There's an editorial that accompanies this. So all in all, lots of great reads in the journal and I'll see you next month. Thank you.
